Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors

Journal of Immunology

Volumn 161, Issue 3, 1998, Pages 1433-1438

  Bonnette, Bernard ^a   Favre, Nathalie ^a   Moutet, Monique ^a   Fromentin, Annie ^a   Solary, Eric ^a   Martin, Monique ^a   Martin, François ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL CLONE; COLON CARCINOMA; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOPHENOTYPING; NONHUMAN; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; COLONIC NEOPLASMS; CULTURE MEDIA, SERUM-FREE; GRAFT REJECTION; IMMUNITY, NATURAL; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, INBRED STRAINS; TUMOR CELLS, CULTURED;

EID: 0032145473     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Martin, F., A. Caignard, J. F. Jeannin, A. Leclerc, and M. S. Martin. 1983. Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int. J. Cancer 32:623.
2. Caignard, A., M. S. Martin, M. F. Michel, and F. Martin. 1985. Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. Int. J. Cancer 36:273.
3. Caignard, A., H. Pelletier, and F. Martin. 1988. Specificity of the immune response leading to protection or enhancement by regressive and progressive variants of a rat colon carcinoma. Int. J. Cancer 42:883.
4. Shimizu, T., M. S. Martin, H. Pelletier, P. Lagadec, and F. Martin. 1989. Effects of cyclosporine on progressive and regressive tumors induced by two cancer lines derived from a single colon carcinoma chemically induced in the rat. Immunobiology. 178:401.
5. Yang, E., and S. J. Korsmeyer. 1996. Molecular thanatopsis: a discourse on the Bc12 family and cell death. Blood 88:386.
6. Vaux, D., S. Cory, and J. Adams. 1988. Bcl-2 promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440.
7. Tsujimoto, Y. 1989. Stress-resistance conferred by high level of bcl-2a protein in human B lymphoblastoid cell. Oncogene 4:1331.
8. Nunez, G., L. London, D. Hockenbery, M. Alexander, J. P. McKearn, and S. J. Korsmeyer. 1990. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hematopoietic cell lines. J. Immunol. 144:3602.
9. Strater, J., H. Walczak, P. H. Krammer, and P. Möller. 1996. Simultaneous in situ detection of mRNA and apoptotic cells by combined hybridization and TUNEL. J. Histochem. Cytochem. 44:1497.
10. Jäättelä, M., M. Benedict, M. Tewari, J. A. Shayman, and V. M. Dixit. 1995. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10:2297.
11. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5. Virology 52:456.
12. Martin, M. S., A. Caignard, A. Hammann, H. Pelletier, and F. Martin. 1987. An immunohistological study of cells infiltrating progressive and regressive tumors induced by two variant subpopulations of a rat colon cancer cell line. Int. J. Cancer 40:87.
13. Dijkstra, C. D., E. A. Dopp, P. Joling, and G. Kraal. 1985. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2, and ED3. Immunology 54:589.
14. Collins, M. K., G. R. Perkins, G. Rodriguez-Tarduchy, M. A. Nieto, and A. Lopez-Rivas. 1994. Growth factors as survival factors: regulation of apoptosis. Bioessays 16:133.
15. O'Brien, V., S. M. Frisch, and R. L. Juliano. 1996. Expression of the integrin α5 subunit in HT29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation. Exp. Cell Res. 224:208.
16. Sutton, V. R., D. L. Vaux, and J. A. Trapani. 1997. Bcl-2 prevents apoptosis induced by perform and granzyme B, but not that mediated by whole cytotoxic lymphocytes. J. Immunol. 158:5783.
17. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609.
18. Yin, C., M. Knudson, S. J. Korsmeyer, and T. Van Dyke. 1997. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637.
19. Huang, A. Y. C., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961.
20. Mackay, C. R. 1991. T-cell memory: the connection between function, phenotype, and migration pathways. Immunol. Today 12:189.
21. Harding, C. V., and R. Song. 1994. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class l MHC molecules. J. Immunol. 153:4925.
22. Falo, L. D., M. Kovacsovics-Bankowski, K. Thompson, and K. L. Rock. 1995. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat. Med. 1:649.
23. Bellone, M., G. Lezzi, P. Rovere, G. Galati, A. Ronchetti, M. P. Protti, J. Davoust, C. Rugarli, and A. A. Manfredi. 1997. Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159:5391
24. Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207.
25. Damoiseaux, J. G., E. A. Döpp, W. Calame, D. Chao, G. G. MacPherson, and C. D. Dijkstra. 1994. Rat macrophage lysosomal membrane antigen recognized by monoclonal ED1. Immunology 83:140.
26. Bellingan, G. J., H. Caldwell, S. E. M. Howte, I. Dransfield, and C. Haslett. 1996. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J. Immunol. 157:2577.
27. Nair, S., A. M. J. Buiting, R. J. D. Rouse, N. Van Rooijen, L. Huang, and B. T. Rouse. 1995. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int. Immunol. 7:679.
28. Boon, T., and J. Maryanski. 1983. Tumor cell variants with increased immunogenicity obtained by mutagen treatment. Cancer Surv. 4:135.